NYMOX PHARMACEUTICAL CORPORATION Key Management Personnel Compensation
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) reported Key Management Personnel Compensation of $642.90 thousand for the 3-month period ending 2021-09-30, per its 6-K filed 2021-11-12.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:KeyManagementPersonnelCompensation · last filed 2021-11-12
- NYMOX PHARMACEUTICAL CORPORATION key management personnel compensation for the quarter ending 2021-09-30 was $642.90K, a 97.99% increase year-over-year.
- NYMOX PHARMACEUTICAL CORPORATION key management personnel compensation for the quarter ending 2021-06-30 was $185.43K, a 50.65% decline year-over-year.
- NYMOX PHARMACEUTICAL CORPORATION key management personnel compensation for the quarter ending 2021-03-31 was $479.77K, a 11.72% increase year-over-year.
- NYMOX PHARMACEUTICAL CORPORATION key management personnel compensation for the quarter ending 2020-09-30 was $324.71K.
| Period end | Key Management Personnel Compensation 3 month | Key Management Personnel Compensation 6 month | Key Management Personnel Compensation 9 month |
|---|---|---|---|
| 2021-09-30 | $642.90K 6-K · filed 2021-11-12 | $828.33K derived: sum of 2 quarters · filed 2021-11-12 | $1.31M 6-K · filed 2021-11-12 |
| 2021-06-30 | $185.43K 6-K · filed 2021-08-13 | $665.20K 6-K · filed 2021-08-13 | |
| 2021-03-31 | $479.77K 6-K · filed 2021-05-14 | ||
| 2020-09-30 | $324.71K 6-K · filed 2021-11-12 | $700.41K derived: sum of 2 quarters · filed 2021-11-12 | $1.13M 6-K · filed 2021-11-12 |
| 2020-06-30 | $375.70K 6-K · filed 2021-08-13 | $805.13K 6-K · filed 2021-08-13 | |
| 2020-03-31 | $429.43K 6-K · filed 2021-05-14 | ||
| 2018-09-30 | $1.14M 6-K · filed 2018-11-13 | $2.06M derived: sum of 2 quarters · filed 2018-11-13 | $3.07M 6-K · filed 2018-11-13 |
| 2018-06-30 | $914.44K 6-K · filed 2018-08-13 | $1.92M 6-K · filed 2018-08-13 | |
| 2018-03-31 | $1.01B 6-K · filed 2018-05-15 | ||
| 2017-09-30 | $2.31M 6-K · filed 2018-11-13 | $3.66M derived: sum of 2 quarters · filed 2018-11-13 | $5.15M 6-K · filed 2018-11-13 |
| 2017-06-30 | $1.35M 6-K · filed 2018-08-13 | $2.85M 6-K · filed 2018-08-13 | |
| 2017-03-31 | $1.50B 6-K · filed 2018-05-15 |